Studies investigating RANKL levels in CKD patients have demonstrated conflicting findings (24–26), whereas OPG concentrations have consistently been reported to be higher in haemodialysis patients (24, 27, 28), which could reflect a compensatory protective mechanism to moderate bone remodelling. This evidence concerns the gene TNFSF11 and chronic kidney disease.